Dysregulation of CSC signaling like Hippo/YAP1, Wnt/β-catenin, and hedgehog (Hh) have been implicated in the maintenance of tumor and in conferring therapy resistance [19–22]. This evidence concerns the gene YAP1 and neoplasm.